Back to Search
Start Over
The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.
- Source :
-
Experimental hematology [Exp Hematol] 2016 Oct; Vol. 44 (10), pp. 924-930.e1. Date of Electronic Publication: 2016 Jul 12. - Publication Year :
- 2016
-
Abstract
- For many years, splenectomy has been used to treat immune thrombocytopenia (ITP), and this procedure benefits approximately two-thirds of the treated patients. Although splenectomy may raise platelet counts, antibody-coated platelets and cytotoxic T lymphocytes appear to persist or can change over time. To better understand how the spleen may affect anti-platelet immune responses, we used a murine model of ITP demonstrating both antibody-mediated and T lymphocyte-mediated thrombocytopenia. Mice with severe combined immunodeficiency (SCID) were either splenectomized or not and transfused with splenocytes from CD61 (GPIIIa) knockout mice immunized against CD61(+) platelets. Platelet counts and anti-platelet antibody levels were performed weekly. After 4 weeks, the mice were sacrificed, and lymphoid organs were harvested and examined by flow cytometry to quantify CD4(+)CD25(+)FoxP3(+) Tregs and conventional cross-presenting XCR1(+) and tolerizing SIRPĪ±+ dendritic cells. The results indicate that compared with control non-splenectomized mice, thrombocytopenia was improved and anti-platelet antibody production was significantly diminished in all splenectomized mice that received immune splenocytes. Splenectomized SCID mice also had a marked reduction in Tregs in the thymus together with an increased proportion of both thymic dendritic cell subsets that correlated with increased platelet counts. Of interest, although splenectomy diminished anti-platelet antibody production and raised platelet counts, marrow megakaryocyte densities were still significantly reduced in mice that received immune splenocytes. These results suggest that the spleen in murine ITP not only is the primary site responsible for platelet destruction, but it also controls, to a significant extent, the antibody response against platelets and the migration patterns of lymphocyte subsets.<br /> (Copyright © 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Biomarkers
Bone Marrow pathology
Dendritic Cells immunology
Dendritic Cells metabolism
Disease Models, Animal
Female
Histocompatibility Antigens Class I immunology
Integrin beta3 genetics
Integrin beta3 immunology
Leukocyte Count
Lymphocytes metabolism
Lymphocytes pathology
Megakaryocytes metabolism
Mice
Mice, Knockout
Phenotype
Platelet Count
Purpura, Thrombocytopenic, Idiopathic metabolism
Purpura, Thrombocytopenic, Idiopathic pathology
Purpura, Thrombocytopenic, Idiopathic therapy
Spleen pathology
Splenectomy
T-Lymphocytes, Regulatory immunology
T-Lymphocytes, Regulatory metabolism
T-Lymphocytes, Regulatory pathology
Thymocytes immunology
Thymocytes metabolism
Autoantibodies immunology
Blood Platelets immunology
Lymphocytes immunology
Purpura, Thrombocytopenic, Idiopathic immunology
Spleen immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2399
- Volume :
- 44
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Experimental hematology
- Publication Type :
- Academic Journal
- Accession number :
- 27417974
- Full Text :
- https://doi.org/10.1016/j.exphem.2016.07.004